Jazz Pharmaceuticals (JAZZ)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Jazz Pharmaceuticals | JAZZ | Healthcare | Biotechnology | 94 | 16.7% |
| Current Price (09/20) | $129.21 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 2,034.6 | |||
| Sales Growth Forecast | 13.2% | |||
| Net Profit Margin | 45.9% | |||
| Projected Shares Outstanding | 62.01 | |||
| EPS - Five year Forecast | $27.97 | |||
| Average P/E Ratio | 10.0 | |||
| Projected Average Price | $279.68 | |||
| Price Appreciation (Annualized) | 16.7% | |||
| Annual Dividend Yield | 0.0% | |||
| Projected Annual Return | 16.7% | |||
| Quality | ||||
| Financial Strength | 86 | 21.5 | ||
| EPS Stability | 94 | 23.5 | ||
| Industry Sales Growth Rate | 16.5% | 10.0 | ||
| Industry Net Profit Margin | 29.0% | 19.8 | ||
| Calculated Quality Rating | 74.7 | |||
| Fool CAPS | ||||
Total Players
306
Outperforms
67
Underperforms
All-Stars (70)
55
Outperforms (79%)
15
Underperforms
|
||||
| Fundamental Data Updated: 06/28/2019 | ||||